{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:03:20Z","timestamp":1786712600908,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1213\/ane.0b013e31824a95ad","type":"journal-article","created":{"date-parts":[[2012,3,14]],"date-time":"2012-03-14T08:47:27Z","timestamp":1331714847000},"page":"1017-1025","source":"Crossref","is-referenced-by-count":6,"title":["Novel Double and Single Ryanodine Receptor 1 Variants in Two Austrian Malignant Hyperthermia Families"],"prefix":"10.1213","volume":"114","author":[{"given":"Alexius","family":"Kaufmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Kraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Michalek-Sauberer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Weindlmayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans G.","family":"Kress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinand","family":"Steinboeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas G.","family":"Weigl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210902","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.bbamcr.2010.11.009","article-title":"Mechanistic models for muscle diseases and disorders originating in the sarcoplasmic reticulum.","volume":"1813","author":"MacLennan","year":"2011","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"R2-16-20210902","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-2-21","article-title":"Malignant hyperthermia.","volume":"2","author":"Rosenberg","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"R3-16-20210902","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/humu.20356","article-title":"Mutations in RYR1 in malignant hyperthermia and central core disease.","volume":"27","author":"Robinson","year":"2006","journal-title":"Hum Mutat"},{"key":"R4-16-20210902","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1213\/ane.0b013e3181ae94c7","article-title":"Novel variants near the central domain of RYR1 in two malignant hyperthermia-susceptible families from Taiwan.","volume":"109","author":"Chen","year":"2009","journal-title":"Anesth Analg"},{"key":"R5-16-20210902","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/bja\/aep061","article-title":"Mutation screening of the RYR1-cDNA from peripheral B-lymphocytes in 15 Swedish malignant hyperthermia index cases.","volume":"102","author":"Broman","year":"2009","journal-title":"Br J Anaesth"},{"key":"R7-16-20210902","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0005-2736(93)90375-A","article-title":"Specific modifications of the membrane fatty acid composition of human myotubes and their effects on the muscular sodium channels.","volume":"1145","author":"Brinkmeier","year":"1993","journal-title":"Biochim Biophys Acta"},{"key":"R9-16-20210902","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1086\/515454","article-title":"Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle.","volume":"60","author":"Monnier","year":"1997","journal-title":"Am J Hum Genet"},{"key":"R10-16-20210902","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1016\/S0021-9258(19)83641-4","article-title":"A new generation of Ca2 indicators with greatly improved fluorescence properties.","volume":"260","author":"Grynkiewicz","year":"1985","journal-title":"J Biol Chem"},{"key":"R12-16-20210902","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/ALN.0b013e318182a93b","article-title":"Novel ryanodine receptor mutation that may cause malignant hyperthermia.","volume":"109","author":"Kaufmann","year":"2008","journal-title":"Anesthesiology"},{"key":"R13-16-20210902","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/(SICI)1098-1004(1998)11:1<45::AID-HUMU7>3.0.CO;2-K","article-title":"Novel mutations at a CpG dinucleotide in the ryanodine receptor in malignant hyperthermia.","volume":"11","author":"Manning","year":"1998","journal-title":"Hum Mutat"},{"key":"R14-16-20210902","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00000542-200503000-00007","article-title":"Screening of the entire ryanodine receptor type 1 coding region for sequence variants associated with malignant hyperthermia susceptibility in the North American population.","volume":"102","author":"Sambuughin","year":"2005","journal-title":"Anesthesiology"},{"key":"R15-16-20210902","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/0888-7543(91)90084-R","article-title":"A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia.","volume":"11","author":"Gillard","year":"1991","journal-title":"Genomics"},{"key":"R16-16-20210902","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/0888-7543(91)90083-Q","article-title":"Cosegregation of porcine malignant hyperthermia and a probable causal mutation in the skeletal muscle ryanodine receptor gene in backcross families.","volume":"11","author":"Otsu","year":"1991","journal-title":"Genomics"},{"key":"R17-16-20210902","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/bja\/79.3.332","article-title":"Detection of a novel mutation at amino acid position 614 in the ryanodine receptor in malignant hyperthermia.","volume":"79","author":"Quane","year":"1997","journal-title":"Br J Anaesth"},{"key":"R18-16-20210902","doi-asserted-by":"crossref","first-page":"34918","DOI":"10.1074\/jbc.M205487200","article-title":"Identification of a dantrolene-binding sequence on the skeletal muscle ryanodine receptor.","volume":"277","author":"Paul-Pletzer","year":"2002","journal-title":"J Biol Chem"},{"key":"R19-16-20210902","doi-asserted-by":"crossref","first-page":"11618","DOI":"10.1074\/jbc.275.16.11618","article-title":"Postulated role of interdomain interaction within the ryanodine receptor in Ca2 channel regulation.","volume":"275","author":"Yamamoto","year":"2000","journal-title":"J Biol Chem"},{"key":"R20-16-20210902","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1086\/301748","article-title":"Identification of novel mutations in the ryanodine-receptor gene (RYR1) in malignant hyperthermia: genotype-phenotype correlation.","volume":"62","author":"Manning","year":"1998","journal-title":"Am J Hum Genet"},{"key":"R21-16-20210902","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0022-2836(82)90515-0","article-title":"A simple method for displaying the hydropathic character of a protein.","volume":"157","author":"Kyte","year":"1982","journal-title":"J Mol Biol"},{"key":"R22-16-20210902","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1213\/01.ANE.0000118110.90277.D2","article-title":"4-chloro-m-cresol cannot detect malignant hyperthermia equivocal cells in an alternative minimally invasive diagnostic test of malignant hyperthermia susceptibility.","volume":"99","author":"Weigl","year":"2004","journal-title":"Anesth Analg"},{"key":"R23-16-20210902","first-page":"149","article-title":"Classification of malignant hyperthermia-equivocal patients by 4-chloro-M-cresol.","volume":"85","author":"Gilly","year":"1997","journal-title":"Anesth Analg"},{"key":"R24-16-20210902","doi-asserted-by":"crossref","first-page":"21022","DOI":"10.1074\/jbc.M600670200","article-title":"Amino acid residues gln4020 and lys4021 of the ryanodine receptor type 1 are required for activation by 4-chloro-m-cresol.","volume":"281","author":"Fessenden","year":"2006","journal-title":"J Biol Chem"},{"key":"R26-16-20210902","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/bja\/aer132","article-title":"Malignant hyperthermia: pharmacology of triggering.","volume":"107","author":"Hopkins","year":"2011","journal-title":"Br J Anaesth"},{"key":"R27-16-20210902","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/bja\/86.2.283","article-title":"Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia.","volume":"86","author":"Urwyler","year":"2001","journal-title":"Br J Anaesth"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0b013e31824a95ad","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:26:31Z","timestamp":1786112791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201205000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0b013e31824a95ad","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}